Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Myers, M. W.  [Clear All Filters]
Journal Article
J. A. Kaye, Myers, M. W., and Jick, H., Acetaminophen and the risk of renal and bladder cancer in the general practice research database, Epidemiology, vol. 12, pp. 690-4, 2001.
M. W. Myers, Vasilakis, C., Kaufman, M. R., and Jick, H., Antihypertensive drugs and the risk of idiopathic aplastic anaemia, Br J Clin Pharmacol, vol. 49, pp. 604-8, 2000.
S. S. Jick, Stender, M., and Myers, M. W., Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents, Diabetes Care, vol. 22, pp. 2067-71, 1999.
S. Seshadri, Zornberg, G. L., Derby, L. E., Myers, M. W., Jick, H., and Drachman, D. A., Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease, Arch Neurol, vol. 58, pp. 435-40, 2001.
H. Jick, Jick, S. S., Gurewich, V., Myers, M. W., and Vasilakis, C., Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components, Lancet, vol. 346, pp. 1589-93, 1995.
S. S. Jick, Myers, M. W., and Jick, H., Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components, Lancet, vol. 354, pp. 302-3, 1999.
H. Jick, Myers, M. W., and Dean, A. D., The risk of sulfasalazine- and mesalazine-associated blood disorders, Pharmacotherapy, vol. 15, pp. 176-81, 1995.
M. W. Myers and Jick, H., Terfenadine and risk of acute liver disease, Br J Clin Pharmacol, vol. 46, pp. 251-3, 1998.
L. E. Derby, Myers, M. W., and Jick, H., Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke, Br J Clin Pharmacol, vol. 47, pp. 565-9, 1999.
[Page last reviewed 6 September 2019]